DAVOS.CH,DOEHNER.W, RAUCHH.AUS M, CICOIRA M, FRANCIS DP, COATS AJ, CLARK AL, ANKER SD. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail, 2003; 9: 29-35
CURTIS JP, SELTER JG, WANG Y, RATHORE SS, JOVIN IS, JADBABAIE F, KOSIBOROD M, PORTNAY EL, SOKOL SI, BADER F, KRUMHOLZ HM. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med, 2005;165: 55-61.
KISTORP C, FABER J, GALATIUS S, GUSTAFSSON F, FRYSTYK J, FLYVBJERG A, HILDEBRANDT P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation, 2005;112: 1 756-62
ANKER SD, NEGASSA A, COATS AJ, AFZAL R, POOLE-WILSON PA, COHN JN, YUSUF S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet, 2003 ; 361 : 1 077-83.
HARRINGTON D, ANKER SD, CHUA TP, WEBB-PEPLOE KM, PONIKOWSKI PP, POOLE-WILSON PA, COATSAJ. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol, 1997; 30: 1758-64
FLOREA VG, MOON J, PENNELL DJ, DOEHNER W, COATS AJ, ANKER SD. Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. Int J Cardiol, 2004 ; 97 : 15-20
Schneider S. Supports nutritionnels dans les maladies d'organe : Insuffisance cardiaque. Session Nutrition. Entretiens de Bichat, Paris, 14 septembre 2012.
CICOIRA M, BOLGER AP, DOEHNER W, RAUCHHAUS M, DAVOS C, SHARMA R, AL-NASSER FO, COATS AJ.High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Cytokine, 2001;15: 80-6.
ANKER SD, CHUA TP, PONIKOWSKI P et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation, 1997 ; 96 : 526-34.
ANKER SD, PONIKOWSKI P, VARNEY S, CHUATP, CLARKAL, WEBB-PEPLOE KM, HARRINGTON D, KOX WJ, POOLE-WILSON PA, COATS AJ. Wasting as independent risk factor for mortality in chronic heart failure. Lancet, 1997 ;349 : 1050-3.
LE ROUX CW, GHATEI MA, GIBBS JS, BLOOM SR. The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension. Heart, 2005;91: 241-2
WITTE KK, CLARK AL, CLELAND JG.Chronic heart failure and micronutrients. J Am Coll Cardiol, 2001;37: 1 765-74.
BURKE MP, OPESKIN K. Fulminant heart failure due to selenium deficiency cardiomyopathy (Keshan disease). Med Sci Law, 2002;42: 10-3.
SOLE MJ, JEEJEEBHOY KN. Conditioned nutritional requirements: therapeutic relevance to heart failure. Herz, 2002 ; 27 : 174-8.
HEYMSFIELD SB, CASPER K. Congestive heart failure: clinical management by use of continuous nasoenteric feeding. Am J Clin Nutr, 1989; 50: 539-44. 11.
Shirley J Am Acad Nurse Pract 2008; 20:326-32)
WITTE KK, CLARK AL, CLELAND JG. Chronic heart failure and micronutrients.J Am Coll Cardiol, two hundred]1;37: 1 765-74.
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory from the American Heart Association. Circulation. 2017.
WITTE KK, NIKITIN NP, PARKER AC, VON HAEHLING S, VOLK HD, ANKER SD, CLARK AL, CLELAND JG. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic. heart failure. Eur Heart J, 2005;26: 2 238-44.
Nagaya et al. Circulation 2004; 110:3676-9)
Temel,J.S. et al; Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials; Lancet Oncol; Publié en ligne le 19 février 2016)
VAN DEN BELD A.W., BOTS M.L., JANSSEN J.A., POLS H.A., LAMBERTS S.W., GROBBEE D.E.: Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol, 2003, 157, 25-31.
Cuneo. Lancet 1989; 1(8642):838-9),
O’Driscoll. Lancet 1997; 349:1068)
Ronan T et all (université Genève) : activité physique, nutrition et insuffisance cardiaque chronique : EM/consult : Nutrition clinique et métabolisme : vol N°28, pages 327-335(décembre 2014)
Deswal et al. Circulation 1999 ;99 :3224-6) (Bozkurt et al. Circulation 2001; 103:1044-7)
Anker et al. The syndrome of cardiac cachexia. Int J Cardiol2002; (85:51-66)
E.Esposito et S. Cuzzocrea, « TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma », Curr Med Chem, vol. 16, 2009, p. 3152−3167